🕵️ Tvardi Therapeutics, Inc. ($TVRD)
SEC insider & ownership activity, last 12 months · CIK 1346830 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Sporos Bioventures LLC | 8.9% | 13G | Aug 8, 2025 | filing ↗ | |
| Solas Tvardi Sidecar LLC | 8.1% | 13G | Apr 22, 2025 | filing ↗ | |
| Solas Bioventures Fund II, LP | 8.1% | 13G | Apr 22, 2025 | filing ↗ | |
| Solas Partners II, LLC | 8.1% | 13G | Apr 22, 2025 | filing ↗ | |
| Slate PATH Capital LP | 7.5% | 13G | Aug 14, 2025 | filing ↗ | |
| David Greenspan | 7.5% | 13G | Aug 14, 2025 | filing ↗ | |
| David J. Tweardy | 7.0% | 13G | May 2, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 17, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 7, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 9, 2026 | filing ↗ |
| Earnings (2.02) | May 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 8, 2026 | filing ↗ |
| Earnings (2.02) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Other events (8.01) | Mar 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 16, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 16, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 19, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 19, 2025 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Other events (8.01) | Oct 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 13, 2025 | filing ↗ |
| Earnings (2.02) | Aug 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 14, 2025 | filing ↗ |